---
title: Buy Lenalidomide 10mg Caps Online
description: Lenalidomide 10mg capsules treat multiple myeloma and certain anemias. Order verified quality from our secure online pharmacy for dependable delivery.
type: product
language: en 
url: https://liabilis.com/order-lenalidomide-online-en.html
availability: in_stock
shipping:
  - type: Standard Airmail
    price: 10.00
    currency: USD
    area: Worldwide
    time: 14-21 days
  - type: Tracked Express
    price: 30.00
    currency: USD
    area: Worldwide
    tracking: true
    time: 5-9 days
price_min: 81.99
price_max: 688.99
currency: USD
offers:
  - name: 10mg x 10 caps
    price: 81.99
  - name: 10mg x 20 caps
    price: 159.99
  - name: 10mg x 40 caps
    price: 315.99
  - name: 10mg x 60 caps
    price: 464.99
  - name: 10mg x 90 caps
    price: 688.99
---

# Buy Lenalidomide 10mg Caps Online

Lenalidomide is an immunomodulatory agent primarily for multiple myeloma in combination with other therapies. It also treats myelodysplastic syndromes in adults. This oral medication supports bone marrow function. Our pharmacy offers Lenalidomide in 10mg caps.

## Pricing and Options

| Dosage | Pack Size | Price (USD) | Price Per Pill | Status |
| :--- | :--- | :--- | :--- | :--- |
| **10mg** | 10 caps | **$81.99** | $8.20 | In Stock |
| **10mg** | 20 caps | **$159.99** | $8.00 | In Stock |
| **10mg** | 40 caps | **$315.99** | $7.90 | In Stock |
| **10mg** | 60 caps | **$464.99** | $7.75 | In Stock |
| **10mg** | 90 caps | **$688.99** | $7.66 | In Stock |


[Buy Now](https://liabilis.com/order-lenalidomide-online-en.html)

## Introduction 
Lenalidomide is an oral immunomodulatory medication used primarily in the treatment of blood-related cancers. It contains the active ingredient **lenalidomide**, is supplied as a **capsule** in a **10 mg** strength, and belongs to the class of thalidomide analogues. The drug is approved for several malignancies, including multiple myeloma and certain myelodysplastic syndromes. In addition to its anticancer activity, lenalidomide is investigated for a limited number of other conditions, though those uses have not received formal regulatory endorsement.

---

## Quick Reference Facts 

**Active Ingredient** 
: Lenalidomide 

**Form** 
: Capsule 10 mg 

**Primary and Off-Label Uses** 
: • Multiple myeloma (approved) 
: • Myelodysplastic syndromes with del(5q) (approved) 
: • Mantle-cell lymphoma (approved) 
: • Follicular lymphoma (approved) 
: • Off-label: chronic graft-versus-host disease, certain solid tumours, autoimmune disorders 

---

## What is Lenalidomide? 
Lenalidomide is a synthetic derivative of thalidomide engineered to retain immunomodulatory and anti-angiogenic properties while reducing neurotoxicity. It is classified as an **immunomodulatory imide drug (IMiD)**. The compound was first developed by Celgene (now part of Bristol-Myers Squibb) and received its first U.S. FDA approval in 2005 for refractory multiple myeloma. As a **generic** medication, lenalidomide is the same chemical entity found in branded products such as Revlimid® and is considered bioequivalent to those formulations. Generic availability offers substantial cost savings without compromising efficacy or safety.

---

## How Lenalidomide Works 
Lenalidomide exerts its therapeutic effect by binding to the cereblon (CRBN) component of the CRL4-CRBN E3 ubiquitin ligase complex. This interaction redirects the ligase to target specific transcription factors-most notably Ikaros (IKZF1) and Aiolos (IKZF3)-for ubiquitination and proteasomal degradation. The loss of these factors leads to:

* **Enhanced T-cell and natural-killer (NK) cell activity**, boosting immune surveillance against malignant cells. 
* **Inhibition of pro-angiogenic cytokines** (e.g., VEGF), reducing tumor blood-vessel formation. 
* **Direct antiproliferative effects** on plasma cells and myelodysplastic progenitors.

Pharmacokinetically, lenalidomide is rapidly absorbed (peak plasma concentrations within 2-4 hours), exhibits a bioavailability of ~80 %, and is primarily eliminated unchanged by the kidneys (≈90 %). Renal function therefore influences dosing, and dose adjustments are recommended for patients with impaired clearance.

---

## Conditions Treated with Lenalidomide 

- **Multiple Myeloma (relapsed/refractory)** - Lenalidomide, often combined with dexamethasone, prolongs progression-free and overall survival by targeting malignant plasma cells and modulating the tumor microenvironment. 
- **Myelodysplastic Syndromes (MDS) with del(5q)** - The drug corrects the ineffective hematopoiesis characteristic of this cytogenetic subgroup, leading to transfusion independence in many patients. 
- **Mantle-Cell Lymphoma** - When used after prior therapy, lenalidomide induces remission by enhancing immune-mediated clearance of malignant B-cells. 
- **Follicular Lymphoma** - As a single agent or in combination, it improves response rates in patients who have failed rituximab-based regimens. 

Each indication benefits from lenalidomide’s dual actions: direct tumor cell inhibition and stimulation of the host’s immune response.

---

## Is Lenalidomide the Right Medication for You? 

Lenalidomide is most appropriate for adults diagnosed with the approved hematologic malignancies listed above, particularly when conventional chemotherapy has failed or when a targeted oral therapy is preferred. Patients with adequate renal function (creatinine clearance ≥ 30 mL/min) and no contraindicating conditions (e.g., pregnancy, severe hypersensitivity) are typical candidates. 

Conversely, lenalidomide is **not** suitable for individuals who are pregnant, nursing, or planning conception, given its potent teratogenicity. Those with uncontrolled infections, recent major surgery, or marked cytopenias may require alternative therapies or dose modifications. A thorough hematologic and renal assessment, coupled with close monitoring for blood-count changes, is essential before initiating treatment.

---

## Buying Lenalidomide from [our online pharmacy](https://liabilis.com/order-lenalidomide-online-en.html) 

### Why Choose Our Service? 
Accessing lenalidomide can be challenging due to cost constraints or limited stock in local pharmacies. Our platform delivers a reliable, discreet solution for patients seeking a trustworthy source of this essential medication.

### Quality & Safety Assurance 
We partner with licensed international pharmacies to ensure quality and authenticity. Every batch undergoes independent verification against regulatory standards, providing confidence that the product matches the specifications of the original brand.

### Pricing & Access 
Because we supply the generic formulation, price points are considerably lower than those of branded equivalents. This enables patients to obtain the full prescribed course without the financial burden that often accompanies specialty oncology drugs.

### Discreet Delivery 
Orders are packaged in plain, unmarked envelopes and dispatched via express courier (typically within 7 days) or standard airmail (approximately 3 weeks). All shipments comply with privacy regulations, safeguarding your personal information throughout the process.

---

## Use: Dosing, Missed Dose, Overdose 

**Standard dosing (adult)** 
- Multiple myeloma: 25 mg orally once daily on a 21-day cycle (5 days on, 2 days off). 
- Myelodysplastic syndromes (del 5q): 10 mg orally once daily continuously. 

*Dose adjustments* are required for renal impairment (e.g., 5 mg daily for creatinine clearance 30-49 mL/min). 

**Missed dose** 
- If you realize a missed dose within 12 hours, take it immediately. 
- If more than 12 hours have passed, skip the missed tablet and resume the regular schedule; do not double-dose. 

**Overdose** 
- Symptoms may include severe nausea, vomiting, dizziness, or profound neutropenia. 
- Seek emergency medical care promptly. Activated charcoal is ineffective because lenalidomide is rapidly absorbed; supportive care and hematologic monitoring are the mainstays of treatment. 

**Practical precautions** 
- Take capsules with water; they may be taken with or without food. 
- Avoid alcohol, as it can exacerbate fatigue and myelosuppression. 
- Do not operate heavy machinery or drive until you know how the drug affects you, especially during the first few weeks. 

---

## Safety Information 

### ⚠️ Who Should Not Take Lenalidomide 
- **Pregnant or breastfeeding individuals** - teratogenic risk is high; pregnancy testing is mandatory before initiation and monthly thereafter. 
- **Patients with severe hypersensitivity** to lenalidomide or any capsule excipients. 
- **Individuals with uncontrolled infections** or active thromboembolic disease without anticoagulation. 

### Common Side Effects 
- **Neutropenia** (low neutrophil count) - occurs in up to 50 % of patients; regular blood-count monitoring is required. 
- **Thrombocytopenia** (low platelets) - may lead to easy bruising; dose reduction often mitigates severity. 
- **Fatigue, diarrhea, and rash** - typically mild to moderate and often improve with supportive care. 

### Serious Side Effects (Seek Immediate Medical Help) 
- **Venous thromboembolism (VTE)** - signs include swelling, pain, or redness of a limb, sudden chest pain, or shortness of breath. 
- **Severe neutropenia with fever** - indicates possible infection; treat as a medical emergency. 
- **Grade 3-4 skin reactions** (e.g., Stevens-Johnson syndrome). 

### Drug & Food Interactions 
- **Anticoagulants (warfarin, DOACs)** - increased bleeding risk; monitor INR or relevant coagulation parameters. 
- **CYP inducers (rifampin, carbamazepine)** - may slightly lower lenalidomide exposure; clinical relevance is modest but warrants observation. 
- **Vaccines** - live attenuated vaccines are contraindicated during treatment due to immunosuppression. 

---

## Off-Label and Investigational Uses of Lenalidomide 

- **Chronic graft-versus-host disease (cGVHD)** - small phase II trials suggest improvement in skin and oral manifestations when combined with steroids. 
- **Solid tumours (e.g., breast, prostate)** - early-phase studies explore synergistic activity with checkpoint inhibitors, though efficacy remains unproven. 
- **Autoimmune disorders (e.g., systemic lupus erythematosus)** - anecdotal reports indicate modulation of auto-antibody production, but robust data are lacking. 

These applications have not received formal regulatory approval; their use should be confined to clinical trial settings or under specialist supervision.

---

## Storage & Handling 

- **Temperature:** Store capsules at 20-25 °C (68-77 °F); excursions between 15-30 °C are acceptable. 
- **Light/Humidity:** Keep the container tightly closed, protected from excessive moisture and direct sunlight. 
- **Expiry:** Do not use beyond the printed expiration date; discard any capsules that appear discoloured or damaged. 
- **Disposal:** Return unused medication to a pharmacy take-back program or follow local hazardous-waste guidelines. 

---

## Frequently Asked Questions 

**Practical Use & Lifestyle** 

- **Can I travel internationally with lenalidomide?** 
 Yes, but you should carry the original prescription label and a signed letter from your physician. Some countries require a customs declaration for controlled substances. 

- **Should I avoid any specific foods while taking lenalidomide?** 
 There are no strict dietary restrictions, but high-fat meals may delay absorption slightly. Maintaining a balanced diet supports overall health during treatment. 

- **Is it safe to drink alcohol while on lenalidomide?** 
 Moderate alcohol intake is generally tolerated, yet excessive consumption can worsen fatigue and increase liver strain. Discuss your drinking habits with your healthcare provider. 

**Product & Formulation Details** 

- **What does a lenalidomide capsule look like?** 
 The 10 mg generic capsule is typically opaque, white-to-off-white, and may be film-coated to mask any taste. Appearance can vary slightly between manufacturers. 

- **Can the capsule be split or crushed?** 
 Lenalidomide capsules should be swallowed whole. Splitting or crushing may affect drug stability and absorption; consult a pharmacist before altering the form. 

**Regulatory & Safety Nuances** 

- **Will lenalidomide show up on a standard drug test?** 
 Routine employment drug screens do not detect lenalidomide, as it is not a substance of abuse. However, therapeutic drug monitoring may be performed in specialized clinical settings. 

- **Is lenalidomide permitted for import into the United States for personal use?** 
 The FDA allows import of a 90-day supply of a non-controlled prescription medication for personal use, provided it is not for resale and the product is FDA-approved. Verify import regulations specific to your state. 

- **Are there special considerations for elderly patients?** 
 Older adults often have reduced renal function, which may necessitate lower dosing. They are also more susceptible to cytopenias, so frequent blood-count checks are advisable. 

**Scientific & Clinical Curiosity** 

- **What was the original indication that led to lenalidomide’s development?** 
 Lenalidomide was created to improve upon thalidomide’s anticancer activity while minimizing its neurotoxic side effects, initially targeting refractory multiple myeloma. 

- **How does lenalidomide differ from the brand Revlimid®?** 
 The generic formulation contains the identical active molecule, dosage strength, and bioavailability as Revlimid®, and must meet the same regulatory standards for safety and efficacy. 

---

## Glossary 

**Cereblon (CRBN)** 
: A protein that forms part of an E3 ubiquitin ligase complex; lenalidomide binds to it, altering the degradation of specific transcription factors. 

**Ikaros (IKZF1) and Aiolos (IKZF3)** 
: Transcription factors involved in lymphocyte development; their degradation by lenalidomide enhances immune-cell activity against cancer. 

**Myelosuppression** 
: Suppression of bone-marrow activity leading to reduced blood cell production, commonly manifested as neutropenia or thrombocytopenia. 

**Teratogenicity** 
: The ability of a substance to cause birth defects when exposure occurs during pregnancy. 

**Pharmacokinetics** 
: The study of how a drug is absorbed, distributed, metabolized, and eliminated by the body. 

---

## Disclaimer 

The information presented about **Lenalidomide** is intended for general educational purposes and does not substitute professional medical consultation. All therapeutic choices, including any off-label applications, must be made under the direct guidance of a qualified healthcare practitioner. Readers are presumed to be responsible adults capable of informed health decisions. [our online pharmacy](https://liabilis.com/order-lenalidomide-online-en.html) provides a convenient avenue for obtaining lenalidomide, particularly for individuals encountering limited access or high costs through conventional channels, or who seek a verified generic alternative. Before initiating, altering, or stopping any medication, please discuss the plan with your physician.